Position in OVID
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$77,576
+$13,554 QoQ
Shares Held
28,839
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BLAIR WILLIAM & CO/IL holds $157,670,224 across 60 Biotechnology names. OVID ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
513,573 | $36,283,932 | |
| 2 | ARGX |
Argenx SE
|
27,666 | $25,667,684 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
416,766 | $16,258,041 | |
| 4 | EXEL |
Exelixis, Inc.
|
243,215 | $13,233,328 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,400 | $9,139,832 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
756,277 | $7,555,207 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
23,450 | $5,739,856 | |
| 8 | NGNE |
Neurogene Inc.
|
146,905 | $4,620,162 |
All Filings in OVID
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,576 | 28,839 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $64,022 | 28,839 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $42,932 | 26,339 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,615 | 25,089 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,289 | 22,089 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $7,188 | 23,039 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $21,518 | 23,039 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $37,806 | 32,039 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $23,868 | 31,039 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $73,013 | 23,939 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $69,796 | 21,676 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $84,775 | 22,077 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $76,512 | 23,327 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $62,766 | 24,328 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $45,250 | 24,328 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $57,459 | 31,228 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $67,140 | 31,228 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $183,266 | 58,365 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $291,634 | 90,852 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $325,913 | 96,998 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $456,531 | 116,760 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $629,057 | 156,482 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $317,994 | 137,660 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $945,584 | 164,736 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $571,587 | 77,556 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $193,700 | 65,000 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||